A retrospective cohort study of evaluating prognostic factors of patients with advanced lung cancer treated with anlotinib
Latest Information Update: 19 Nov 2021
At a glance
- Drugs Catequentinib (Primary)
- Indications Adenocarcinoma; Carcinoma; Lung cancer; Small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Nov 2021 New trial record
- 01 Oct 2021 Results published in the Journal of International Medical Research